All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
Lawmakers Clash Over COVID Vaccine Safety at House Hearing
Is the CDC’s Vaccine Adverse Event Reporting System (VAERS) a reliable way to document potential problems with the COVID-19 vaccine and other vaccines? Members of
February 16, 2024